Related Experiment Videos
[Increased p-homocysteine--a risk factor for thrombosis]
1Center for haemofili og trombose, klinisk immunologisk afdeling, Arhus Universitetshospital, Skejby Sygehus.
Ugeskrift for Laeger
|August 6, 1998
Summary
Elevated homocysteine levels increase the risk of blood clots and premature arteriosclerosis. Supplementation with folic acid and vitamin B6 can normalize homocysteine and potentially reduce thrombosis risk.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Clinical Nutrition
Context:
- Homocysteine, an amino acid, is linked to various health conditions.
- Elevated homocysteine levels are observed with aging, in males, and due to genetic or nutritional factors.
- Renal failure also contributes to increased homocysteine.
Purpose:
- To review the role of homocysteine in thrombosis and arteriosclerosis.
- To explore the correlation between homocysteine and lifestyle factors.
- To discuss the impact of homocysteine on endothelial function and coagulation.
Summary:
- Homocysteine levels naturally rise with age and are higher in middle-aged men.
- Elevated homocysteine is a significant risk factor for arterial and venous thrombosis, and premature arteriosclerosis.
- Positive correlations exist with smoking, blood pressure, and cholesterol; negative correlation with physical activity.
Impact:
- Understanding homocysteine's role aids in assessing cardiovascular risk.
- Folic acid and vitamin B6 supplementation can normalize homocysteine levels.
- Further research is needed to confirm the reduction in thrombosis risk following homocysteine normalization.